About the Event

GU Update Ribeirão Preto is now in its third edition!

This course will cover the latest developments in the treatment of genitourinary tumors in the fields of surgery, clinical oncology, and radiation oncology. It will focus primarily on the latest findings from the 2026 ASCO Genitourinary Cancers Symposium.

We will cover three sections:
• Prostate Cancer
• Bladder Cancer
• Kidney Cancer 

We will be joined by nationally renowned speakers, moderators, and panelists.

You're our special guest—come join us!

Dr. Júlia De Stéfani and Dr. Fábio Zola 
Program Coordinators

March 21, 2026, 8:30 a.m.
Event Timer
00
day(s)
00
hour(s)
00
minute(s)
00
second(s)

WHEN WILL THE EVENT TAKE PLACE?

DATE:

March 21, 2026.

SCHEDULE:

8:00 a.m. to 12:30 p.m.

LOCATION:

TRYP by Wyndham
Room: Santos Dumont
Address: Av. Dr. José Cesário Monteiro da Silva, 150 - Jardim Nova Alianca, Ribeirão Preto - SP

TARGET AUDIENCE:

Clinical Oncologists, Urologists, Radiation Oncologists, Pathologists, and medical residents.

Confirmed Attendees

Dr. Luciola Pontes

Clinical Oncologist – São Paulo, SP | CRM 126540, RQE 45390

Dr. Daniel Preto

Clinical Oncologist – Barretos, São Paulo | CRM 168127, RQE 90299

Dr. Daniel Girardi

Clinical Oncologist – Brasília/DF – CRM 23440, RQE 19007

Dr. Júlia De Stéfani

Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 157519, RQE 77458

Dr. Fábio Zola

Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 92536, RQE 23178

Dr. Rodolfo Borges dos Reis

Urologist – Ribeirão Preto, São Paulo | CRM 67294, RQE 57869

Dr. Carlos Fruet

Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 145861, RQE 102461

Dr. Tiago Bovo

Uro-Oncologist – Ribeirão Preto, São Paulo | CRM 94246, RQE 58781

Dr. Helena Palocci

Geriatric Oncology – Ribeirão Preto, São Paulo | CRM 209983, RQE 116558

Dr. Gustavo Miranda

Urologist – Ribeirão Preto, São Paulo | CRM 144377, RQE 60593

Dr. Guilherme Mendes

Radiation Oncologist – Ribeirão Preto, São Paulo | CRM 156806, RQE 67820

Dr. Fernanda Bombarda

Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 175832

Dr. Harley Francisco

Radiation Oncologist – Ribeirão Preto, São Paulo | CRM 108563, RQE 39279/40017

Dr. Thais Inácio de Carvalho

Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 89701, RQE 75984

Dr. Murilo Andrade

Urologist – Ribeirão Preto, São Paulo | CRM 116423, RQE 33267

Dr. Guilherme Franco

Urologist – Ribeirão Preto, São Paulo | CRM 176358, RQE 92238

Dr. Priscila Pavaneli

Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 184981, RQE 100968

Dr. Joana Marra

Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 156838, RQE 102690

Dr. Leandro Colli

Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 130109

Dr. Marcelo Baptistussi

Urologist – Ribeirão Preto, São Paulo | CRM 63701, RQE 53657

Dr. Rafael Feres

Urologist – Ribeirão Preto, São Paulo | CRM 135396, RQE 62932

Dr. Luís César Zaccaro

Urological Oncologist – Ribeirão Preto, São Paulo | CRM 117720, RQE 31712

Dr. Fernanda Oliveira

Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 212669, RQE 109777

Dr. Silvana Vale

Clinical Oncologist – São Paulo, SP | CRM 114273, RQE 98490

Dr. Milena Tariki

Clinical Oncologist – São Paulo, SP | CRM 115749, RQE 47479

Dr. Carolina Alves

Clinical Oncologist – Salvador, Bahia | CRM 25221, RQE 15315

Dr. Matheus Aquino

Clinical Oncologist – Ribeirão Preto, São Paulo | CRM 185624, RQE 132605

Dr. Armando Abrantes

Urologist – Ribeirão Preto, São Paulo | CRM 48746, RQE 44014

Schedule

8:00 a.m. – Breakfast – Meet the Professor 
8:20 a.m. – Welcome and opening remarks: Dr. Júlia De Stéfani and Dr. Fábio Zola 

Session 1: Prostate Cancer | Moderator: Dr. Fábio Zola

8:30 a.m. – Prostate Cancer – What is the importance of assessing genomic mutations? Is mHRR testing alone sufficient? What tests should be performed in 2026?
Speaker: Dr. Carlos Fruet
08:45 – Advanced Prostate Cancer. Is it time for radioligand therapy (LuPSMA) at CPSCm?
Speaker: Dr. Luciola Pontes
09:00 – Minimizing Damage: Surgical approaches to preserve continence and sexual function in patients with prostate cancer.
Speaker: Dr. Tiago Bovo
09:15 – Under Discussion: Testosterone Replacement Therapy in patients with prostate cancer undergoing follow-up.
Speaker: Dr. Rodolfo Borges dos Reis
9:30 a.m. – Androgen deprivation in elderly patients: functional, cognitive, and metabolic impact—invisible effects that alter outcomes.
Speaker: Dr. Helena Palocci
9:45 a.m. – Discussion
Discussants: Dr. Thaís Carvalho and Dr. Murilo Andrade

10:00 a.m. – Bayer Satellite Symposium: CPHSm: From Intensification to Personalized Treatment
Speaker: Dr. Daniel Girardi

10:20 – Coffee Break

 

Session 2: Bladder Cancer | Moderator: Dr. Harley Francisco

10:35 – High-risk non-muscle-invasive urothelial carcinoma of the bladder: the surgeon’s approach and discussion on combining immunotherapy with BCG?
Speaker: Dr. Gustavo Miranda
10:50 – Bladder preservation: where are we now, and where are we headed?
Speaker: Dr. Guilherme Mendes
11:05 – Enforfumabe vedotin and pembrolizumab in locally advanced or metastatic disease, and future prospects
Speaker: Dr. Fernanda Bombarda
11:20 – Discussion
Discussants: Dr. Daniel Girardi and Dr. Guilherme Franco

 

11:35 – AstraZeneca Satellite Symposium: NIAGARA in Practice: From Evidence to Clinical Experience with CBMI Patients
Speaker: Dr. Daniel Preto

 

Session 3: Kidney Cancer | Moderator: Dr. Júlia De Stéfani

12:05 – Beyond the Protocols: Strategic Decisions in the First-Line Treatment of Advanced Renal Cancer.
Speaker: Dr. Daniel Preto
12:20 – Discussion
Panelists: Dr. Priscila Pavanelli, Dr. Luciola Pontes, and Dr. Daniel Girardi

12:30 p.m. – Closing Remarks: Dr. Fábio Zola and Dr. Júlia De Stéfani

Lunch will be served at the hotel restaurant 

Diamond Sponsor

Gold Sponsor

Silver Sponsor

Tryp By Wyndham | Room: Santos Dumont
Address: Av. Dr. José Cesário Monteiro da Silva, 150 – Jardim Nova Alianca, Ribeirão Preto – SP, 14026-600

Achievement